0001837607 2026-07-09 2026-07-09 0001837607 1 2026-07-09 2026-07-09 0001837607 2 2026-07-09 2026-07-09 0001837607 3 2026-07-09 2026-07-09 0001837607 4 2026-07-09 2026-07-09 0001837607 5 2026-07-09 2026-07-09 0001837607 6 2026-07-09 2026-07-09 0001837607 7 2026-07-09 2026-07-09 0001837607 8 2026-07-09 2026-07-09 iso4217:USD pure S-1 S-1/A EX-FILING FEES 333-297327 0001837607 AEON Biopharma, Inc. N/A N/A S-1 AEON Biopharma, Inc. false Equity Class A Common Stock, par value $0.0001 per share, underlying Five-Year Milestone Warrants true 2156250.00 0.0001381 297.78 true Equity Class A Common Stock, par value $0.0001 per share true 14375000.00 1985.19 true Equity Pre-Funded Warrants true 0.00 true Equity Class A Common Stock underlying Pre-Funded Warrants true 0.00 true Equity Two-Year Milestone Warrants true 0.00 true Equity Class A Common Stock, par value $0.0001 per share, underlying Two-Year Milestone Warrants true 14375000.00 1985.19 true Equity Five-Year Milestone Warrants true 0.00 true Equity Class A Common Stock, par value $0.0001 per share, underlying Five-Year Milestone Warrants true 14375000.00 1985.19 45281250.00 6253.35 5955.57 0.00 297.78 Note 1.a. In accordance with Rule 416(a), the Registrant is also registering an indeterminate number of additional shares of Common Stock that shall be issuable pursuant to Rule 416 to prevent dilution resulting from share splits, share dividends or similar transactions. Note 1.b. Estimated solely for purposes of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933. Includes the offering price of the Class A Common Stock, par value $0.0001, of the Registrant (the "Common Stock") that the representative of the underwriters has the option to purchase to cover over-allotments, if any. Note 1.c Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act, the proposed maximum aggregate offering price of the five-year milestone warrants is equal to $16,531,250 (which is 115% of $14,375,000). See Offering Notes 1.a. and 1.b. See Offering Notes 1.a. and 1.b. In accordance with Rule 457(g) under the Securities Act, because the Common Stock underlying the warrants are registered hereby, no separate registration fee is required with respect to the warrants registered hereby. See Offering Note 3. See Offering Note 3. See Offering Notes 1.a. and 1.b. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act, the proposed maximum aggregate offering price of the two-year milestone warrants is equal to $14,375,000 (which is 100% of $14,375,000). See Offering Note 3. See Offering Note 1.